Clinical Trials Browser

Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Esophageal Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

NCT04028245 2025-08-07

SPARC-1

Phase EARLY_PHASE1 Active not recruiting

17 enrolled

Genitourinary

Carcinoma, Renal Cell

NCT04301414 2025-08-07

Neo-Red-P

Phase EARLY_PHASE1 Completed

26 enrolled

Genitourinary

Prostatic Neoplasms

NCT07067905 2025-07-16

Clinical Evaluation of [68Ga]Ga-XT771 PET for Diagnosis in Patients With Glioblastoma and Clear Cell Renal Cell Carcinoma

Phase EARLY_PHASE1 Recruiting

15 enrolled

CNSGenitourinary

Carcinoma, Renal Cell, Glioblastoma

NCT07023848 2025-06-17

PET Image Exploration of 89Zr-labeled Antibody Fragments Targeting HER2 in Patients With Malignant Tumors

Phase EARLY_PHASE1 Enrolling by invitation

10 enrolled

BreastGastrointestinalGenitourinary

Breast Neoplasms, Carcinoma, Transitional Cell, Stomach Neoplasms

NCT07023861 2025-06-17

The Exploration of Novel Radionuclide-labeled HER2-targeting Antibodies in the Diagnosis of HER2-positive Malignancies

Phase EARLY_PHASE1 Enrolling by invitation

20 enrolled

BreastGastrointestinalGenitourinary

Breast Neoplasms, Carcinoma, Transitional Cell, Stomach Neoplasms

NCT06419348 2025-06-04

99mTc-QULIC-5-P1 SPECT Imaging in Patients With Prostate Cancer

Phase EARLY_PHASE1 Recruiting

30 enrolled

Genitourinary

Prostate Cancer Stage

NCT03392181 2025-05-23

PET/MRI for the Staging of Newly Diagnosed Prostate Cancer

Phase EARLY_PHASE1 Active not recruiting

48 enrolled

Genitourinary

Prostatic Neoplasms

NCT05852041 2025-05-22

rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveillance

Phase EARLY_PHASE1 Recruiting

40 enrolled

Genitourinary

Prostatic Neoplasms

NCT03987217 2025-05-14

Resistance Training +/- Creatine for Metastatic Prostate Cancer Patients

Phase EARLY_PHASE1 Completed

73 enrolled

Genitourinary

Fatigue, Prostatic Neoplasms, Sedentary Behavior

NCT04305925 2025-05-13

Focal Laser Ablation of Prostate Cancer

Phase EARLY_PHASE1 Active not recruiting

10 enrolled

Genitourinary

Prostatic Neoplasms

NCT05851365 2025-05-08

Magnetic Resonance (MR) Imaging With Hyperpolarized Bicarbonate (13C) to Measure Tissue pH in Prostate Cancer

Phase EARLY_PHASE1 Active not recruiting

1 enrolled

Genitourinary

Prostatic Neoplasms

NCT02671552 2025-05-02

Contrast-Enhanced Ultrasound in Predicting Treatment Response in Patients With Kidney Cancer Undergoing Cryosurgery

Phase EARLY_PHASE1 Withdrawn

Genitourinary

Carcinoma, Renal Cell

NCT03810651 2025-04-27

Pencil Beam Scanning in Patients With Renal Tumors

Phase EARLY_PHASE1 Recruiting

28 enrolled

Genitourinary

Carcinoma, Renal Cell, Wilms Tumor

NCT03661437 2025-04-11

Systemic Light Exposure in Preventing Frailty in Older Patients With Prostate Cancer on Hormonal Therapy

Phase EARLY_PHASE1 Completed

33 enrolled

Genitourinary

Prostatic Neoplasms

NCT02420977 2025-03-19

Evaluation of PSMA-based PET as an Imaging Biomarker in Prostate Cancer

Phase EARLY_PHASE1 Completed

23 enrolled

Genitourinary

Advanced Prostate Cancer

NCT06864572 2025-03-07

[68Ga]Ga-P17-079 in the Diagnosis and Treatment of Metastatic Prostate Cancer

Phase EARLY_PHASE1 Enrolling by invitation

40 enrolled

Genitourinary

Prostatic Neoplasms

Clinical Trials

99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer

Rituximab Neoadjuvant Therapy in Patients With Prostate Cancer Scheduled to Undergo Radical Prostatectomy

Immunological Effects of Vitamin D Replacement Among Black/African American Prostate Cancer Patients

Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility Study

Safety and Tolerability Study of 68Ga/177Lu-BRP-020063 in Advanced Solid Tumors

Evaluating in Vivo PARP-1 Expression With 18F-FluorThanatrace Positron Emission Tomography (PET/CT) in Prostate Cancer

Image-guided Focal Brachytherapy Utilizing Combined 18F-DCFPyl PET/CT

Image-Guided (68Ga-PSMA-11 PET/CT) Prostate Biopsy for the Diagnosis of Prostate Cancer in Men With Prior Negative/Inconclusive Biopsy

Safety and Efficacy Evaluation of LC-K76 in Patients With Metastatic Hormone-Sensitive Prostate Cancer

HCQ in Resectable Localized Prostate Cancer

A Platform Study of Epigenetic Therapy Before Prostatectomy in Men With Prostate Cancer

161Tb-LNC1011

Imaging and Genomic Biomarkers to Predict Response in Prostate Cancer

18Fluorine-Fluciclovine PET/CT for Staging Muscle Invasive Bladder Cancer Preceding Radical Cystectomy

Study of Allogeneic Anti-PSMA CAR-NK Cell for Metastatic Castration-Resistant Prostate Cancer

An Exploratory Clinical Study Evaluating the Safety and Efficacy of Allogeneic CAR-NK Cell Therapy for Metastatic Castration-resistant Prostate Cancer (mCRPC)

A Study to Determine the Preferred Dose of the Drug, Lisinopril, for Preventing Urinary Toxicity Following Radiotherapy for Prostate Cancer

Nivolumab With or Without Bevacizumab or Ipilimumab Before Surgery in Treating Patients With Metastatic Kidney Cancer That Can Be Removed by Surgery

PERTINENCE

Virtual Histology of the Bladder Wall for Bladder Cancer Staging

Adaptive Abiraterone Therapy for Metastatic Castration Resistant Prostate Cancer

Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer

PragMet

Safety and Efficacy Evaluation of Anti IGF-1R Monoclonal Antibody Combined With Anti-PD-1 Monoclonal Antibody in Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer

A Clinical Study Evaluating the Safety and Efficacy of Local Injection of ACT#001 Chimeric Antigen Receptor T Cells in the Treatment of Castration-Resistant Prostate Cancer

CLONEVO

Testosterone Therapy in Castration Resistant Prostate Cancer

An Investigational Scan (MRI With Dixon Based Sequences) in Detecting Prostate Cancer

Assessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen Suppression

177Lu-P17-087/177Lu-P17-088 in Patients With Metastatic Castration-resistant Prostate Cancer

KSD-201 Treatment for Advanced Clear Cell Renal Cell Carcinoma: an Early Exploratory Clinical Study

Re-treatment 225Ac-J591 for mCRPC

Copper Cu-64 TP3805 PET/CT in Imaging Patients With Urothelial Cancer Undergoing Surgery or Biopsy

Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues

SPARC-1

Neo-Red-P

Clinical Evaluation of [68Ga]Ga-XT771 PET for Diagnosis in Patients With Glioblastoma and Clear Cell Renal Cell Carcinoma

PET Image Exploration of 89Zr-labeled Antibody Fragments Targeting HER2 in Patients With Malignant Tumors

The Exploration of Novel Radionuclide-labeled HER2-targeting Antibodies in the Diagnosis of HER2-positive Malignancies

99mTc-QULIC-5-P1 SPECT Imaging in Patients With Prostate Cancer

PET/MRI for the Staging of Newly Diagnosed Prostate Cancer

rhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveillance

Resistance Training +/- Creatine for Metastatic Prostate Cancer Patients

Focal Laser Ablation of Prostate Cancer

Magnetic Resonance (MR) Imaging With Hyperpolarized Bicarbonate (13C) to Measure Tissue pH in Prostate Cancer

Contrast-Enhanced Ultrasound in Predicting Treatment Response in Patients With Kidney Cancer Undergoing Cryosurgery

Pencil Beam Scanning in Patients With Renal Tumors

Systemic Light Exposure in Preventing Frailty in Older Patients With Prostate Cancer on Hormonal Therapy

Evaluation of PSMA-based PET as an Imaging Biomarker in Prostate Cancer

[68Ga]Ga-P17-079 in the Diagnosis and Treatment of Metastatic Prostate Cancer